VIENNA, Feb. 14, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced interim data from the Phase 3b STARDUST study. At week 16, 79 percent of patients with moderately to severely active Crohn's disease (CD) achieved clinical response1 and 67 percent were in clinical remiss

MARKHAM, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of February 2020, representing $0.936 per Common Sh

Dubai will kick off the 45th edition of the World Hospital Congress (WHC) in 2021, under the theme ‘Achieving Sustainability and How Should We Look in 2030?’. Organized by the Dubai Health Authority (DHA) in collaboration with the International Hospital Federation (IHF) and INDEX Conferences and Exhibitions – a member of INDEX Holding, the 4-day annual World Hospital Congress, will be held from the 5th to the 8th of December, 2021. IHF 2021 World Hospital Congress

Senseonics Holdings, Inc. a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system, today announced an agreement with Companion Medical to integrate Eversense® CGM System real-time glucose data with the Companion Medical InPen™ smart system for insulin delivery. For people living with insulin-dependent diabetes, this news means that real-time glucose data will continuously be

STOCKHOLM, Feb. 14, 2020 /PRNewswire/ -- Recruitment for NefIgArd part A completed on plan and budget "In the last quarter of 2019, we achieved a major milestone: the full recruitment of 200 patients for Part A of our pivotal Phase 3 study, NefIgArd. We continue to expect to read out top line data in Q4 2020 as projected at the start of the study, based on

BEIJING, Feb. 13, 2020 /PRNewswire/ -- A news report by China Daily, Xing Yi in Shanghai:

Appoints Greg Guyatt as Chief Executive Officer, with Robert Marcovitch remaining as non-executive Chairman VAUGHAN, ON, Feb. 13, 2020 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) announced the appointment of

MINNEAPOLIS, Feb. 13, 2020 /PRNewswire/ -- It is not uncommon for children and teens with autism spectrum disorder to struggle with sleep. Trouble falling asleep and staying asleep or refusing to go to bed are just some of the sleep problems they can experience. To help families, neurologists and other healthcare providers make decisions on the best treatments, the

In the news release, miR Scientific Presents Breakthrough New Data on the miR Scientific Sentinel™ Tests for the Detection and Classification of Prostate Cancer at the 2020 ASCO Genitourinary Cancers Symposium (February 13-15 in San Francisco, Calif.), issued 12-Feb-2020 by miR Scientific over PR Newswire, we are advised by the company

VANCOUVER and HOUSTON, TX, Feb. 13, 2020 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal first quarter ended December 31, 201